A Personalised Integrated Care Approach for Service Organisations and Care Models for Patients with rheumatoid arthritis and cardiovascular comorbidity

• Conditions: M05; M06; Seropositive rheumatoid arthritis; Other rheumatoid arthritis

• Registration Number: DRKS00013637
• Lead Sponsor: Heinrich-Heine-Universität Düsseldorf

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-01-17
• Study Completion: 2019-06-18
• Results First Posted: 2021-05-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

rheumatoid Arthritis, cardiovascular comorbidity and/or cardiovascular risik profil

Exclusion Criteria

Participation in clinical trial

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proof-of concept<br>Primary end-points:<br>•User acceptance, adaptability and usability factors (patients and physicians perspective) of the PICASO platform and the integrated features (physician and patient dashboard, home monitoring devices, patient reported outcome measurement, care plans)<br>•Active participation of patients and their informal carers in the care process and management reflected by the ongoing use of the PICASO platform <br>•Improved outcome (health and quality of life and improved activity by creating consciousness for self-management through the visualization of current values and activity as well as reminder functions)<br>•Evaluate the impact and workflows of the platform on the participating stakeholders and society<br>•Reduced number and length of admissions to hospital compared to the individual patients’ history (preceding 6 months)<br>•Integrate PICASO into existing technical infrastructures<br>•Secure and accurate handling of data and data sharing in PICASO<br>

Secondary Outcome Measures

Name	Time	Method
evaluation questionnaires